{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:47Z","timestamp":1761562007255},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s13312-015-0686-y","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T02:11:08Z","timestamp":1438049468000},"page":"613-615","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sevelamer hydrochloride for tumor lysis syndrome-related hyperphosphatemia"],"prefix":"10.1007","volume":"52","author":[{"given":"L","family":"Harsha Prasada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,29]]},"reference":[{"key":"686_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s13312-014-0377-0","volume":"51","author":"L Satyanarayana","year":"2014","unstructured":"Satyanarayana L, Asthana S, Labani SP. Childhood cancer incidence in India: A review of population-based cancer registries. Indian Pediatr. 2014;51:218\u201320.","journal-title":"Indian Pediatr."},{"key":"686_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1008366814109","volume":"10","author":"S Advani","year":"1999","unstructured":"Advani S, Pai S, Venzon D, Adde M, Kurkure PK, Nair CN, et al. Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999;10:167\u201376.","journal-title":"Ann Oncol."},{"key":"686_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12098-012-0824-7","volume":"80","author":"A Rajendran","year":"2013","unstructured":"Rajendran A, Bansal D, Marwaha RK. Tumor lysis syndrome. Indian J Pediatr 2013;80:50\u20134.","journal-title":"Indian J Pediatr"},{"key":"686_CR4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","volume":"29","author":"GM Chertow","year":"1997","unstructured":"Chertow GM, Burke SK, Lazarus JM, Stenzel KH, Wanbolt D, Goldberg D, et al. Poly [allylanmine hydrochloride] (Renagel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis. 1997;29:66\u201371.","journal-title":"Am J Kidney Dis."},{"key":"686_CR5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00467-003-1298-7","volume":"18","author":"H Mahdavi","year":"2003","unstructured":"Mahdavi H, Kuizon, BD, Gales B, Wang HJ, Elashoff RM, Salusky IB. Sevelamer hydrochloride: An effective phosphate binder in dialyzed children. Pediatr Nephrol. 2003;18:1260\u20134.","journal-title":"Pediatr Nephrol."},{"key":"686_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40265-013-0054-y","volume":"73","author":"F Malberti","year":"2013","unstructured":"Malberti F. Hyperphosphataemia: Treatment options. Drugs. 2013;73:673\u201388.","journal-title":"Drugs."},{"key":"686_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.ajkd.2005.12.039","volume":"47","author":"AK Pieper","year":"2006","unstructured":"Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G., Bonzel K, et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis. 2006;47:625\u201335.","journal-title":"Am J Kidney Dis."},{"key":"686_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11255-004-7135-5","volume":"37","author":"E Mitsopoulos","year":"2005","unstructured":"Mitsopoulos E, Griveas I, Zanos S, Anagnostopoulos K, Giannakou A, Pavlitou A, et al. Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride. Int Urol Nephrol. 2005;37:321\u20138.","journal-title":"Int Urol Nephrol."},{"key":"686_CR9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1592\/phco.26.3.410","volume":"26","author":"LE Storms","year":"2006","unstructured":"Storms LE, Chicella MF, Dice JE. Sevelamer therapy for pediatric end-stage renal disease. Pharmacotherapy. 2006;26:410\u20133","journal-title":"Pharmacotherapy."},{"key":"686_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pbc.21478","volume":"51","author":"S Abdullah","year":"2008","unstructured":"Abdullah S, Diezi M, Sung L, Dupuis LL, Geary D, Abla O. Sevelamer hydrochloride: A novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children. Pediatr Blood Cancer. 2008;51:59\u201361.","journal-title":"Pediatr Blood Cancer."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-015-0686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-015-0686-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-015-0686-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:42Z","timestamp":1559490102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-015-0686-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s13312-015-0686-y","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}